CEO Doubles Down. Second Buy in a Month.
ProQR's CEO just put another $261,000 into stock at $1.74, and this isn't his first trip to the well. Two insiders have bought in the past 30 days, which is the kind of cluster pattern that carries real weight, especially with a repeat buyer at the top. The chart backs it up too. RSI sits at 54, momentum's building, and both short and medium-term trends read Buy with support at $1.51 underneath the stock. Healthcare's been choppy on a weekly basis even with solid longer-term gains, so this isn't a layup, but a CEO writing a second check at these levels tells you where he thinks the floor is.
The Filing
| Ticker | PRQR |
| Company | ProQR Therapeutics N.V. |
| Insider | Boer Daniel Anton De, Chief Executive Officer |
| Buy amount | $261,000 |
| Filing date | July 13, 2026 |
| Conviction | Interesting · 60/100 |
| Setup type | Accumulation |
Ultimate members received this analysis in real time.